| ［1］ |
Willemsen M, Linkutė R, Luiten RM, et al. Skin⁃resident memory T cells as a potential new therapeutic target in vitiligo and melanoma［J］. Pigment Cell Melanoma Res, 2019,32（5）:612⁃622. doi: 10.1111/pcmr.12803.
|
| ［2］ |
Boniface K, Seneschal J. Vitiligo as a skin memory disease: the need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells［J］. Exp Dermatol, 2019,28（6）:656⁃661. doi: 10.1111/exd.13879.
|
| ［3］ |
Akondy RS, Fitch M, Edupuganti S, et al. Origin and differentiation of human memory CD8 T cells after vaccination［J］. Nature, 2017,552（7685）:362⁃367. doi: 10.1038/nature24633.
|
| ［4］ |
Youngblood B, Hale JS, Kissick HT, et al. Effector CD8 T cells dedifferentiate into long⁃lived memory cells［J］. Nature, 2017,552（7685）:404⁃409. doi: 10.1038/nature25144.
|
| ［5］ |
Mackay LK, Rahimpour A, Ma JZ, et al. The developmental pathway for CD103（+）CD8+ tissue⁃resident memory T cells of skin［J］. Nat Immunol, 2013,14（12）:1294⁃1301. doi: 10.1038/ni.2744.
|
| ［6］ |
Remmerswaal E, Hombrink P, Nota B, et al. Expression of IL⁃7Rα and KLRG1 defines functionally distinct CD8+ T⁃cell populations in humans［J］. Eur J Immunol, 2019,49（5）:694⁃708. doi: 10.1002/eji.201847897.
|
| ［7］ |
Topham DJ, Reilly EC. Tissue⁃resident memory CD8+ T cells: from phenotype to function［J］. Front Immunol, 2018,9:515. doi: 10.3389/fimmu.2018.00515.
|
| ［8］ |
Gauthier L, Corgnac S, Boutet M, et al. Paxillin binding to the cytoplasmic domain of CD103 promotes cell adhesion and effector functions for CD8+ resident memory T cells in tumors［J］. Cancer Res, 2017,77（24）:7072⁃7082. doi: 10.1158/0008⁃5472.CAN⁃17⁃1487.
|
| ［9］ |
Mackay LK, Braun A, Macleod BL, et al. Cutting edge: CD69 interference with sphingosine⁃1⁃phosphate receptor function regulates peripheral T cell retention［J］. J Immunol, 2015,194（5）:2059⁃2063. doi: 10.4049/jimmunol.1402256.
|
| ［10］ |
Shiow LR, Rosen DB, Brdicková N, et al. CD69 acts downstream of interferon⁃alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs［J］. Nature, 2006,440（7083）:540⁃544. doi: 10.1038/nature04606.
|
| ［11］ |
Park CO, Kupper TS. The emerging role of resident memory T cells in protective immunity and inflammatory disease［J］. Nat Med, 2015,21（7）:688⁃697. doi: 10.1038/nm.3883.
|
| ［12］ |
Jiang X, Clark RA, Liu L, et al. Skin infection generates non⁃migratory memory CD8+ T（RM） cells providing global skin immunity［J］. Nature, 2012,483（7388）:227⁃231. doi: 10.1038/nature10851.
|
| ［13］ |
Hondowicz BD, An D, Schenkel JM, et al. Interleukin⁃2⁃dependent allergen⁃specific tissue⁃resident memory cells drive asthma［J］. Immunity, 2016,44（1）:155⁃166. doi: 10.1016/j.immuni.2015.11.004.
|
| ［14］ |
Lili Y, Yi W, Ji Y, et al. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo［J/OL］. PLoS One, 2012,7（5）:e37513. doi: 10.1371/journal.pone.0037513.
|
| ［15］ |
Rao A, Gupta S, Dinda AK, et al. Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation［J］. Br J Dermatol, 2012,166（6）:1230⁃1236. doi: 10.1111/j.1365⁃2133.2012.10886.x.
|
| ［16］ |
Cavalié M, Ezzedine K, Fontas E, et al. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo⁃controlled study［J］. J Invest Dermatol, 2015,135（4）:970⁃974. doi: 10.1038/jid.2014.527.
|
| ［17］ |
Boniface K, Jacquemin C, Darrigade AS, et al. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3［J］. J Invest Dermatol, 2018,138（2）:355⁃364. doi: 10.1016/j.jid.2017.08.038.
|
| ［18］ |
Richmond JM, Strassner JP, Zapata L Jr, et al. Antibody blockade of IL⁃15 signaling has the potential to durably reverse vitiligo［J］. Sci Transl Med, 2018,10（450）:eaam7710. doi: 10. 1126/scitranslmed.aam7710.
|
| ［19］ |
Cheuk S, Schlums H, GallaisSérézal I, et al. CD49a expression defines tissue⁃resident CD8+ T cells poised for cytotoxic function in human skin［J］. Immunity, 2017,46（2）:287⁃300. doi: 10.1016/j.immuni.2017.01.009.
|
| ［20］ |
Riding RL, Richmond JM, Harris JE. Mouse model for human vitiligo［J］. Curr Protoc Immunol, 2019,124（1）:e63. doi: 10.1002/cpim.63.
|
| ［21］ |
Richmond JM, Strassner JP, Rashighi M, et al. Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo［J］. J Invest Dermatol, 2019,139（4）:769⁃778. doi: 10.1016/j.jid.2018.10.032.
|
| ［22］ |
Samji T, Khanna KM. Understanding memory CD8+ T cells［J］. Immunol Lett, 2017,185:32⁃39. doi: 10.1016/j.imlet.2017.02.012.
|
| ［23］ |
Roberts AD, Ely KH, Woodland DL. Differential contributions of central and effector memory T cells to recall responses［J］. J Exp Med, 2005,202（1）:123⁃133. doi: 10.1084/jem.20050137.
|
| ［24］ |
Enamorado M, Iborra S, Priego E, et al. Enhanced anti⁃tumour immunity requires the interplay between resident and circulating memory CD8+ T cells［J］. Nat Commun, 2017,8:16073. doi: 10. 1038/ncomms16073.
|
| ［25］ |
Adachi T, Kobayashi T, Sugihara E, et al. Hair follicle⁃derived IL⁃7 and IL⁃15 mediate skin⁃resident memory T cell homeostasis and lymphoma［J］. Nat Med, 2015,21（11）:1272⁃1279. doi: 10. 1038/nm.3962.
|
| ［26］ |
Pan Y, Tian T, Park CO, et al. Survival of tissue⁃resident memory T cells requires exogenous lipid uptake and metabolism［J］. Nature, 2017,543（7644）:252⁃256. doi: 10.1038/nature21379.
|
